We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Kodiak Sciences
KOD
$2.52B
| $567K | 0.01% |
+5,000
| New | +$683K |
|
427
iShares US Consumer Discretionary ETF
IYC
$1.16B
| $565K | 0.01% |
7,552
+352
| +5% | +$25.6K |
|
428
Fulgent Genetics
FLGT
$558M
| $558K | 0.01% |
+5,777
| New | +$596K |
|
|
SLY
429
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $554K | 0.01% |
5,893
+839
| +17% | +$76K |
|
430
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$254M
| $548K | 0.01% |
17,370
-1,195
| -6% | -$36.2K |
|
431
DraftKings
DKNG
$12.2B
| $547K | 0.01% |
8,913
-1,300
| -13% | -$78.1K |
|
432
Live Oak Bancshares
LOB
$1.99B
| $547K | 0.01% |
+7,993
| New | +$419K |
|
433
Maximus
MMS
$3.31B
| $547K | 0.01% |
6,143
-8,600
| -58% | -$703K |
|
434
Omeros
OMER
$816M
| $546K | 0.01% |
30,650
+3,175
| +12% | +$61.7K |
|
435
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.93B
| $541K | 0.01% |
5,309
+327
| +7% | +$31.2K |
|
436
Martin Marietta Materials
MLM
$35B
| $539K | 0.01% |
+1,605
| New | +$513K |
|
437
Maravai LifeSciences
MRVI
$1.01B
| $535K | 0.01% |
15,000
-57
| -0.4% | -$1.89K |
|
438
Acadia Pharmaceuticals
ACAD
$4.45B
| $533K | 0.01% |
20,664
+15,000
| +265% | +$660K |
|
439
Vanguard Small-Cap Value ETF
VBR
$37.7B
| $533K | 0.01% |
3,221
+1,034
| +47% | +$163K |
|
440
C3.ai
AI
$1.38B
| $530K | 0.01% |
8,040
+6,040
| +302% | +$702K |
|
441
Fiverr
FVRR
$417M
| $519K | 0.01% |
+2,390
| New | +$586K |
|
442
BP
BP
$107B
| $514K | 0.01% |
21,089
+102
| +0.5% | +$2.46K |
|
443
Zoom
ZM
$26.8B
| $514K | 0.01% |
1,599
+610
| +62% | +$225K |
|
444
Valero Energy
VLO
$88.7B
| $512K | 0.01% |
7,147
+57
| +0.8% | +$3.87K |
|
445
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.32B
| $506K | 0.01% |
6,934
-1,492
| -18% | -$109K |
|
446
Hennessy Sustainable ETF
STNC
$92.6M
| $506K | 0.01% |
+20,653
| New | +$510K |
|
447
CSX Corp
CSX
$94.2B
| $505K | 0.01% |
15,699
-591
| -4% | -$18K |
|
448
Fastly Inc
FSLY
$3.26B
| $501K | 0.01% |
7,451
-150
| -2% | -$12.9K |
|
449
Snowflake
SNOW
$93.7B
| $500K | 0.01% |
2,180
+131
| +6% | +$35K |
|
450
DexCom
DXCM
$28.9B
| $494K | 0.01% |
5,500
+692
| +14% | +$65K |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.